Kinetics of Excretion of the Perfluoroalkyl Surfactant cC6O4 in Humans
暂无分享,去创建一个
D. Consonni | S. Fustinoni | R. Mercadante | Simone Cafagna | Silvia Fustinoni | Rosa Mercadante | Giorgia Lainati | Simone Cafagna | Dario Consonni | Giorgia Lainati
[1] D. Consonni,et al. Historical Trend of Exposure to Perfluoroalkyl Surfactants PFOA, ADV, and cC6O4 and its Management in Two Perfluoroalkyl Polymers Plants, Italy , 2023, Annals of work exposures and health.
[2] F. Spyrakis,et al. Lack of interaction of the fluorosurfactant C6O4 with human renal transporters: in vitro/in silico analysis. , 2022, Toxicology.
[3] R. Jain,et al. Serum concentrations of selected perfluoroalkyl substances for US females compared to males as they age. , 2022, The Science of the total environment.
[4] S. Fustinoni,et al. Development and validation of an LC–MS/MS method for the quantitation of 30 legacy and emerging per- and polyfluoroalkyl substances (PFASs) in human plasma, including HFPO-DA, DONA, and cC6O4 , 2021, Analytical and Bioanalytical Chemistry.
[5] J. Gervasoni,et al. Bioanalytical method validation of quantitative mass spectrometry based assay: experimental protocols and regulations , 2018 .
[6] Yu-Mei Tan,et al. Comparative pharmacokinetics of perfluorobutyrate in rats, mice, monkeys, and humans and relevance to human exposure via drinking water. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.
[7] John W. Froehlich,et al. Half-Life of Serum Elimination of Perfluorooctanesulfonate,Perfluorohexanesulfonate, and Perfluorooctanoate in Retired Fluorochemical Production Workers , 2007, Environmental health perspectives.
[8] J. Tuomilehto,et al. A multi-centre study on within-person variability in the urinary excretion of sodium, potassium, calcium, magnesium and creatinine in 8 European centres. , 1986, Human nutrition. Clinical nutrition.
[9] C. Hagengruber,et al. Automated determination of urinary creatinine without sample dilution: theory and practice. , 1986, Clinical Chemistry.